|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0078414,
umls-concept:C0205420,
umls-concept:C0282460,
umls-concept:C0332283,
umls-concept:C0456598,
umls-concept:C0543467,
umls-concept:C0684249,
umls-concept:C0817096,
umls-concept:C1274040,
umls-concept:C1519429,
umls-concept:C1522449
|
|
pubmed:issue |
8
|
|
pubmed:dateCreated |
1995-9-11
|
|
pubmed:abstractText |
To assess the feasibility of concurrent chemotherapy and irradiation (chemoRT) followed by surgery in locally advanced non-small-cell lung cancer (NSCLC) in a cooperative group setting, and to estimate response, resection rates, relapse patterns, and survival for stage subsets IIIA(N2) versus IIIB.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
0732-183X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
13
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
N
|
|
pubmed:pagination |
1880-92
|
|
pubmed:dateRevised |
2007-11-14
|
|
pubmed:meshHeading |
pubmed-meshheading:7636530-Adult,
pubmed-meshheading:7636530-Aged,
pubmed-meshheading:7636530-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:7636530-Carcinoma, Non-Small-Cell Lung,
pubmed-meshheading:7636530-Cisplatin,
pubmed-meshheading:7636530-Combined Modality Therapy,
pubmed-meshheading:7636530-Etoposide,
pubmed-meshheading:7636530-Feasibility Studies,
pubmed-meshheading:7636530-Female,
pubmed-meshheading:7636530-Follow-Up Studies,
pubmed-meshheading:7636530-Humans,
pubmed-meshheading:7636530-Lung Neoplasms,
pubmed-meshheading:7636530-Male,
pubmed-meshheading:7636530-Middle Aged,
pubmed-meshheading:7636530-Neoplasm Staging,
pubmed-meshheading:7636530-Regression Analysis,
pubmed-meshheading:7636530-Remission Induction,
pubmed-meshheading:7636530-Survival Rate,
pubmed-meshheading:7636530-Thoracotomy,
pubmed-meshheading:7636530-United States
|
|
pubmed:year |
1995
|
|
pubmed:articleTitle |
Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small-cell lung cancer: mature results of Southwest Oncology Group phase II study 8805.
|
|
pubmed:affiliation |
Loyola University Medical Center, Maywood, IL, USA.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, U.S. Gov't, P.H.S.,
Multicenter Study,
Clinical Trial, Phase II
|
